Trials / Completed
CompletedNCT04419233
Non-Interventional, Postmarketing Surveillance Study of Nusinersen Sodium Injection
A Multicenter, Non-Interventional, Postmarketing Surveillance Study of Nusinersen Sodium Injection When Used in Routine Medical Practice in China
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 50 (actual)
- Sponsor
- Biogen · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The primary objective of this study is to evaluate the safety of nusinersen sodium injection in the postmarketing setting in China.The secondary objectives are to collect data on the efficacy and the pharmacokinetics of nusinersen sodium injection in the post-marketing setting in China.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Nusinersen Sodium Injection | Administered as specified in the treatment arm. |
Timeline
- Start date
- 2020-11-18
- Primary completion
- 2023-11-21
- Completion
- 2023-11-21
- First posted
- 2020-06-05
- Last updated
- 2023-12-07
Locations
9 sites across 1 country: China
Source: ClinicalTrials.gov record NCT04419233. Inclusion in this directory is not an endorsement.